Published in Ann Surg on November 01, 2000
Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg (2004) 5.10
The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg (2005) 3.46
Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg (2003) 3.16
Preoperative portal vein embolization for extended hepatectomy. Ann Surg (2003) 2.33
Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection. J Gastrointest Surg (2010) 1.81
Portal vein embolization before liver resection: a systematic review. Cardiovasc Intervent Radiol (2012) 1.50
Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified? Ann Surg (2002) 1.45
Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study. Ann Surg (2007) 1.42
Preoperative portal vein embolization in liver cancer: indications, techniques and outcomes. Quant Imaging Med Surg (2015) 1.42
Combined liver resection and reconstruction of the supra-renal vena cava: the Paul Brousse experience. Ann Surg (2006) 1.28
Current treatment for liver metastases from colorectal cancer. World J Gastroenterol (2003) 1.28
Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant. J Am Coll Surg (2012) 1.17
Hepatic vein reconstruction for resection of hepatic tumors. Ann Surg (2002) 1.12
Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy. Ann Surg (2013) 1.10
Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases. Ann Surg Oncol (2013) 1.05
Surgical treatment of hepatocellular carcinoma. HPB (Oxford) (2005) 1.04
Liver failure following partial hepatectomy. HPB (Oxford) (2006) 1.03
Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy. J Gastrointest Surg (2012) 1.02
Standardized liver volumetry for portal vein embolization. Semin Intervent Radiol (2008) 1.01
Outcomes and prognostic factors of cirrhotic patients with hepatocellular carcinoma after radical major hepatectomy. World J Surg (2007) 1.00
Liver resection for cancer. World J Gastroenterol (2001) 0.97
Surgical treatment of hepatocellular carcinoma. Surg Today (2009) 0.97
Extended left hepatectomy--modified operation planning based on three-dimensional visualization of liver anatomy. Langenbecks Arch Surg (2003) 0.95
Quality improvement for portal vein embolization. Cardiovasc Intervent Radiol (2010) 0.93
Volumetric and functional recovery of the remnant liver after major liver resection with prior portal vein embolization : recovery after PVE and liver resection. J Gastrointest Surg (2009) 0.92
Liver regeneration and the atrophy-hypertrophy complex. Semin Intervent Radiol (2008) 0.90
Portal vein embolization for hepatocellular carcinoma. Liver Cancer (2012) 0.90
Sequential arterial and portal vein embolization in patients with cirrhosis and hepatocellular carcinoma: the hospital beaujon experience. Semin Intervent Radiol (2008) 0.88
Current diagnostic and therapeutic approaches for colorectal cancer liver metastasis. Hippokratia (2008) 0.88
Laparoscopic major hepatectomy for colorectal liver metastases in elderly patients: a single-center, case-matched study. Surg Endosc (2014) 0.87
Surgical management of hepatocellular carcinoma. World J Hepatol (2015) 0.87
Sequential transcatheter arterial chemoembolization and portal vein embolization for hepatocellular carcinoma: the university of Tokyo experience. Semin Intervent Radiol (2008) 0.85
Preoperative portal vein embolization for hepatocellular carcinoma: Consensus and controversy. World J Hepatol (2016) 0.84
Uses and limitations of portal vein embolization for improving perioperative outcomes in hepatocellular carcinoma. Semin Oncol (2010) 0.84
Hepatectomy for hepatocellular carcinoma larger than 10 cm: preoperative risk stratification to prevent futile surgery. HPB (Oxford) (2015) 0.84
The role of interventional radiology in the management of hepatocellular carcinoma. Curr Oncol (2014) 0.82
Portal vein embolization: rationale, technique, and current application. Semin Intervent Radiol (2012) 0.82
Management of "very early" hepatocellular carcinoma on cirrhotic patients. World J Hepatol (2014) 0.82
Partial liver volume radioembolization induces hypertrophy in the spared hemiliver and no major signs of portal hypertension. HPB (Oxford) (2013) 0.81
Limiting factors for liver regeneration after a major hepatic resection for colorectal cancer metastases. HPB (Oxford) (2013) 0.80
Development of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panel. J Vasc Interv Radiol (2012) 0.80
Portal vein embolization and ligation for extended hepatectomy. Indian J Surg Oncol (2014) 0.80
Strategies for resection using portal vein embolization: hepatocellular carcinoma and hilar cholangiocarcinoma. Semin Intervent Radiol (2008) 0.79
A critical evaluation of hepatic resection in cirrhosis: optimizing patient selection and outcomes. World J Surg (2005) 0.79
Inferior right hepatic vein-preserving major right hepatectomy for hepatocellular carcinoma in patients with significant fibrosis or cirrhosis. World J Surg (2014) 0.79
Selection criteria for liver resection in patients with hepatocellular carcinoma and chronic liver disease. World J Gastroenterol (2008) 0.78
Effect of branched-chain amino acid supplementation on functional liver regeneration in patients undergoing portal vein embolization and sequential hepatectomy: a randomized controlled trial. J Gastroenterol (2015) 0.78
Improving the quality of liver resection: a systematic review and critical analysis of the available prognostic models. HPB (Oxford) (2014) 0.78
Indications, limitations and maneuvers to enable extended hepatectomy: current trends. World J Gastroenterol (2014) 0.78
Central Hepatectomy versus Extended Hepatectomy for Malignant Tumors: A Propensity Score Analysis of Postoperative Complications. World J Surg (2016) 0.76
Radioembolisation and portal vein embolization before resection of large hepatocellular carcinoma. World J Gastroenterol (2015) 0.76
Liver surgery in the presence of cirrhosis or steatosis: Is morbidity increased? Patient Saf Surg (2008) 0.76
Preoperative selection of patients with colorectal cancer liver metastasis for hepatic resection. World J Gastroenterol (2016) 0.76
Role of portal vein embolization in hepatocellular carcinoma management and its effect on recurrence: a case-control study. World J Surg (2012) 0.76
ALPPS Procedure in Insufficient Hypertrophy After Portal Vein Embolization (PVE). World J Surg (2017) 0.76
Cantlie's plane in major variations of the primary portal vein ramification at the porta hepatis: cutting experiment using cadaveric livers. World J Surg (2003) 0.75
Patient selection for surgical management of primary and metastatic liver cancers: current perspectives. Semin Intervent Radiol (2006) 0.75
Strategies to increase the resectability of hepatocellular carcinoma. World J Hepatol (2015) 0.75
Complications of Portal Vein Embolization: Evaluation on Cross-Sectional Imaging. Korean J Radiol (2015) 0.75
Preoperative portal venous and hepatic arterial embolization of tumor. Semin Intervent Radiol (2008) 0.75
Surgical resection of localized hepatocellular carcinoma: patient selection and special consideration. J Hepatocell Carcinoma (2016) 0.75
Three-Dimensional Quantitative Evaluation of the Segmental Functional Reserve in the Cirrhotic Liver Using Multi-Modality Imaging. Medicine (Baltimore) (2016) 0.75
Acute kidney injury following hepatectomy for hepatocellular carcinoma: incidence, risk factors and prognostic value. HPB (Oxford) (2016) 0.75
Portal vein embolization for induction of selective hepatic hypertrophy prior to major hepatectomy: rationale, techniques, outcomes and future directions. Cancer Biol Med (2016) 0.75
Ventral segment-preserving right hepatectomy in patients with hepatocellular carcinoma. World J Surg (2015) 0.75
Portal vein embolization with n-butyl-cyanoacrylate through an ipsilateral approach before major hepatectomy: single center analysis of 50 consecutive patients. Cancer Imaging (2017) 0.75
Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med (1999) 17.03
Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology (1994) 9.86
Increase in primary liver cancer in the UK, 1979-94. Lancet (1997) 6.15
Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg (1999) 4.97
An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg (1999) 4.26
Surgical anatomy and anatomical surgery of the liver. World J Surg (1982) 3.96
Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery (1990) 3.93
Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg (1993) 3.91
Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57
Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg (1991) 3.12
Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg (1999) 2.86
Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg (1992) 2.76
The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology (1997) 2.57
No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg (1999) 2.47
Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg (2000) 2.32
Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg (1997) 2.28
Accurate measurement of liver, kidney, and spleen volume and mass by computerized axial tomography. Ann Intern Med (1979) 2.11
Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study. Hepatology (1994) 2.02
Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med (1998) 1.93
Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg (1999) 1.92
Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function. Surgery (1984) 1.86
Human liver regeneration after major hepatectomy. A study of liver volume by computed tomography. Ann Surg (1991) 1.74
In vivo hepatic volume determination using sonography and computed tomography. Validation and a comparison of the two techniques. Gastroenterology (1985) 1.71
Hepatectomy: preoperative analysis of hepatic function and postoperative liver failure. Dig Surg (1998) 1.66
Measurement of liver and spleen volume by computed tomography. Assessment of reproducibility and changes found following a selective distal splenorenal shunt. Radiology (1981) 1.65
Preoperative portal vein embolization: an audit of 84 patients. Hepatology (1999) 1.64
Trends in primary liver cancer. Lancet (1998) 1.56
Right or left trisegment portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma. Surgery (1995) 1.52
Dynamics of normal and injured human liver regeneration after hepatectomy as assessed on the basis of computed tomography and liver function. Hepatology (1993) 1.48
Selective percutaneous transhepatic embolization of the portal vein in preparation for extensive liver resection: the ipsilateral approach. Radiology (1996) 1.47
Changes in hepatic lobe volume in biliary tract cancer patients after right portal vein embolization. Hepatology (1995) 1.43
Extension of surgical indications for hepatocellular carcinoma by portal vein embolization. World J Surg (1993) 1.40
Hepatocellular carcinoma. Br J Surg (1998) 1.35
The relationship between hospital volume and outcomes of hepatic resection for hepatocellular carcinoma. Arch Surg (1999) 1.34
A multiple regression equation for prediction of posthepatectomy liver failure. Ann Surg (1984) 1.30
Human liver regeneration after major hepatic resection. A study of normal liver and livers with chronic hepatitis and cirrhosis. Ann Surg (1987) 1.28
Portal vein embolization: utility for inducing left hepatic lobe hypertrophy before surgery. Radiology (1993) 1.20
Efficacy and safety of preoperative percutaneous transhepatic portal embolization with absolute ethanol: a clinical study. Surgery (1997) 1.18
Right portal vein embolization in preparation for major hepatic resection. J Am Coll Surg (1995) 1.17
Radical operation after portal embolization for tumor of hilar bile duct. J Am Coll Surg (1994) 1.10
Regeneration of the un-embolized liver parenchyma following portal vein embolization. J Hepatol (1997) 1.01
New possibilities for major liver surgery in patients with Klatskin tumors or primary hepatocellular carcinoma--an old problem revisited. Hepatogastroenterology (1991) 0.95
Percutaneous transhepatic portal embolization using newly devised catheters: preliminary report. World J Surg (1993) 0.91
Effect of preoperative portal vein embolization on major hepatectomy for advanced-stage hepatocellular carcinomas in injured livers: a preliminary report. Surg Today (1997) 0.90
Efficacy of major hepatic resection for large hepatocellular carcinoma. Hepatogastroenterology (1999) 0.90
Hepatocellular carcinoma: combined hepatic, arterial, and portal venous embolization. Radiology (1986) 0.88
Causes of death in patients undergoing liver surgery. Cancer Treat Res (1994) 0.86
Hepatocellular carcinoma: treatment with a combination of transcatheter arterial chemoembolization and transportal ethanol injection. Radiology (1994) 0.86
Right portal embolization before extended right hepatectomy using laparoscopic catheterization of the ileocolic vein: a prospective study. Surg Laparosc Endosc (1994) 0.85
Effective cases of transcatheter arterioportal chemoembolization with high-dose iodized oil for hepatocellular carcinoma. Cancer Chemother Pharmacol (1994) 0.81
Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N Engl J Med (1996) 5.36
Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science (1998) 4.58
Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med (1993) 4.43
Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg (1996) 4.41
Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet (1975) 4.17
Surgical anatomy and anatomical surgery of the liver. World J Surg (1982) 3.96
Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg (1993) 3.91
Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol (2001) 3.28
A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat Genet (1999) 3.12
Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors. Ann Surg (2000) 3.07
Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol (1999) 2.80
Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg (1992) 2.76
Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis. J Clin Invest (1997) 2.76
Compared efficacy of preservation solutions in liver transplantation: a long-term graft outcome study from the European Liver Transplant Registry. Am J Transplant (2015) 2.71
Reduced-sized orthotopic liver graft in hepatic transplantation in children. Surgery (1984) 2.63
Hepatocellular carcinoma with lymphoid stroma: a tumour with good prognosis after liver transplantation. Histopathology (2000) 2.46
Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol (2001) 2.43
Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg (2000) 2.32
Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med (1985) 2.29
Major hepatic resection under total vascular exclusion. Ann Surg (1989) 2.29
Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg (1997) 2.28
Resection or palliation: priority of surgery in the treatment of hilar cancer. World J Surg (1988) 2.26
Idiopathic disseminated bacillus Calmette-Guérin infection: a French national retrospective study. Pediatrics (1996) 2.14
Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? Combined resection of colorectal liver metastases with peritoneal deposits discovered intra-operatively. Eur J Surg Oncol (2013) 2.09
Liver resections in cirrhotic patients: a Western experience. World J Surg (1986) 2.05
Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg (2003) 2.04
Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology (1995) 2.00
Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet (2000) 1.99
Repeat hepatectomy for colorectal liver metastases. Ann Surg (1997) 1.99
Fatal disseminated Mycobacterium smegmatis infection in a child with inherited interferon gamma receptor deficiency. Clin Infect Dis (1997) 1.96
Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor. Am J Transplant (2010) 1.93
Long term results of Roux-en-Y hepaticojejunostomy. Surg Gynecol Obstet (1978) 1.85
Transfer of symptomatic peanut allergy to the recipient of a combined liver-and-kidney transplant. N Engl J Med (1997) 1.83
Partial portacaval shunt: renaissance of an old concept. Surgery (1992) 1.79
Repeat hepatectomy for recurrent colorectal metastases. Br J Surg (2013) 1.77
Impact of portal vein embolization on long-term survival of patients with primarily unresectable colorectal liver metastases. Br J Surg (2010) 1.73
Comparison of simultaneous or delayed liver surgery for limited synchronous colorectal metastases. Br J Surg (2010) 1.72
Short- and long-term donor morbidity in right lobe living donor liver transplantation: 91 consecutive cases in a European Center. Am J Transplant (2011) 1.70
Hepatic transplantation in Europe. First Report of the European Liver Transplant Registry. Lancet (1987) 1.68
Laparoscopic liver resection of benign liver tumors. Surg Endosc (2002) 1.68
Effect of extended cold ischaemia with UW solution on graft function after liver transplantation. Lancet (1992) 1.68
Major and minor segmentectomies "réglées" in liver surgery. World J Surg (1982) 1.65
The use of operative ultrasound in surgery of primary liver tumors. World J Surg (1987) 1.64
Vascular reconstruction combined with liver resection for malignant tumours. Br J Surg (2013) 1.63
Liver adenomatosis. An entity distinct from liver adenoma? Gastroenterology (1985) 1.62
Liver cell adenomas. A 12-year surgical experience from a specialist hepato-biliary unit. Ann Surg (1988) 1.61
Partial interferon-gamma receptor signaling chain deficiency in a patient with bacille Calmette-Guérin and Mycobacterium abscessus infection. J Infect Dis (2000) 1.58
Emergency liver transplantation for fulminant hepatitis. Ann Intern Med (1987) 1.56
Bronchobiliary fistulas in adults. Ann Surg (1988) 1.55
Gallbladder cancer: the polyp-cancer sequence. Br J Surg (1990) 1.50
Low prevalence of precore mutations in hepatitis B virus DNA in fulminant hepatitis type B in France. J Hepatol (1993) 1.49
Hematobilia resulting from heterotopic stomach in the gallbladder neck. Surgery (1989) 1.48
Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest (1992) 1.45
Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg (1995) 1.45
Portal-systemic shunt in hepatic cirrhosis: does the type of shunt decisively influence the clinical result? Ann Surg (1974) 1.43
Nonrandom distribution of hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cell subsets. J Virol (1999) 1.42
Long-term outcome in patients with adrenal metastases following resection of colorectal liver metastases. Br J Surg (2009) 1.41
[Living donor in liver transplantation. Present and future alternatives]. Gastroenterol Clin Biol (2000) 1.40
[Role of biliary intubation in the diagnosis of acute pancreatitis without known etiology]. Rev Med Interne (1994) 1.39
[Salmonella typhimurium cerebral abscess: rare complication of HIV infection]. Presse Med (1996) 1.39
Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: an 85-case French multicentric report. Am J Transplant (2008) 1.38
European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. Gastroenterology (1999) 1.38
[Adult to adult living-related liver transplantation. The Paul-Brousse Hospital preliminary experience]. Gastroenterol Clin Biol (2001) 1.38
Emergency orthotopic liver transplantation in two patients using one donor liver. Br J Surg (1989) 1.38
The course of hepatitis C virus infection after liver transplantation. Hepatology (1994) 1.38
Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology (1993) 1.36
Split-liver transplantation. The Paul Brousse policy. Ann Surg (1996) 1.35
Interleukin-12 receptor beta1 deficiency in a patient with abdominal tuberculosis. J Infect Dis (2001) 1.34
Segmental liver resection using ultrasound-guided selective portal venous occlusion. Ann Surg (1989) 1.32
Cavernous hemangiomas of the liver: are there any indications for resection? World J Surg (1995) 1.30
Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: experience with 68 liver resections. World J Surg (1995) 1.29
Liver transplantation across ABO blood group barriers. Lancet (1990) 1.29
Place of cryosurgery in the treatment of malignant liver tumors. Ann Surg (1997) 1.29
Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report. Ann Surg (1997) 1.29
Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation. Ann Intern Med (1998) 1.29
Pyogenic liver abscess: an improvement in prognosis. Br J Surg (1988) 1.28
In a novel form of IFN-gamma receptor 1 deficiency, cell surface receptors fail to bind IFN-gamma. J Clin Invest (2000) 1.24
Clinical, immunological, and pathological consequences of Fas-deficient conditions. Lancet (1996) 1.23
Repeat hepatectomy for recurrent malignant tumors of the liver. Surg Gynecol Obstet (1989) 1.23